Overexpression of mitochondrial cholesterol delivery protein, StAR, decreases intracellular lipids and inflammatory factors secretion in macrophages

详细信息    查看全文

• 作者：Yanxia Ning ; Qianming Bai ; Hong Lu ; Xiaobo Li ; William M. P ; ak ; Fengdi Zhao ; Sifeng Chen ; Shunlin Ren ; Lianhua Yin
• 关键词：Steroidogenic acute regulatory protein ; Macrophage ; Cholesterol ; ABCG1 ; ABCA1 ; Mitochondria ; Oxysterol
• 刊名：Atherosclerosis
• 出版年：2009
• 出版时间：May 2009
• 年：2009
• 卷：204
• 期：1
• 页码：114-120
• 全文大小：1053 K

文摘

Hyperlipidemia is one of the most important risk factors for atherosclerosis. This can be amplified by a localized inflammatory response mediated by macrophages. Macrophages are capable of taking up excess cholesterol, and it is well known that delivery of cholesterol to the mitochondria by steroidogenic acute regulatory (StAR) protein is the rate-limiting step for cholesterol degradation in the liver. It has also been shown that overexpression of StAR in hepatocytes dramatically increases the amount of regulatory oxysterols in the nucleus, which play an important role in the maintenance of intracellular lipid homeostasis. The goal of the present study was to determine whether StAR plays a similar role in macrophages. We have found that overexpression of StAR in human THP-1 monocyte-derived macrophages decreases intracellular lipid levels, activates liver X receptor alpha (LXRα) and proliferation peroxysome activator receptor gamma (PPARγ), and increases ABCG1 and CYP27A1 expression. Furthermore, it reduces the secretion of inflammatory factors, and prevents apoptosis. These results suggest that StAR delivers cholesterol to mitochondria where regulatory oxysterols are generated. Regulatory oxysterols can in turn activate nuclear receptors, which increase expression of cholesterol efflux transporters, and decrease secretion of inflammatory factors. These effects can prevent macrophage apoptosis. These results imply a potential role of StAR in the prevention of atherosclerosis.